Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy resTORbio stock

Own resTORbio stock in just a few minutes.


Fact checked

resTORbio, Inc is a biotechnology business based in the US. resTORbio shares (TORC) are listed on the NASDAQ and all prices are listed in US Dollars. resTORbio employs 10 staff and has a market cap (total outstanding shares value) of USD$11.9 million.

How to buy shares in resTORbio

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for resTORbio. Find the stock by name or ticker symbol: TORC. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until resTORbio reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of resTORbio, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of resTORbio. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

resTORbio share price

Use our graph to track the performance of TORC stocks over time.

resTORbio shares at a glance

Information last updated 2020-11-08.
52-week range USD$0.86 - USD$17.22
50-day moving average USD$7.3133
200-day moving average USD$2.6582
Wall St. target price USD$3
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.444

Buy resTORbio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy resTORbio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

resTORbio financials

Gross profit TTM USD$0
Return on assets TTM -38.47%
Return on equity TTM -66.75%
Profit margin 0%
Book value $1.941
Market capitalisation USD$11.9 million

TTM: trailing 12 months

Shorting resTORbio shares

There are currently 560,879 resTORbio shares held short by investors – that's known as resTORbio's "short interest". This figure is 24.7% down from 744,667 last month.

There are a few different ways that this level of interest in shorting resTORbio shares can be evaluated.

resTORbio's "short interest ratio" (SIR)

resTORbio's "short interest ratio" (SIR) is the quantity of resTORbio shares currently shorted divided by the average quantity of resTORbio shares traded daily (recently around 683998.7804878). resTORbio's SIR currently stands at 0.82. In other words for every 100,000 resTORbio shares traded daily on the market, roughly 820 shares are currently held short.

However resTORbio's short interest can also be evaluated against the total number of resTORbio shares, or, against the total number of tradable resTORbio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case resTORbio's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 resTORbio shares in existence, roughly 10 shares are currently held short) or 0.0127% of the tradable shares (for every 100,000 tradable resTORbio shares, roughly 13 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against resTORbio.

Find out more about how you can short resTORbio stock.

resTORbio share dividends

We're not expecting resTORbio to pay a dividend over the next 12 months.

resTORbio share price volatility

Over the last 12 months, resTORbio's shares have ranged in value from as little as $0.86 up to $17.22. A popular way to gauge a stock's volatility is its "beta".

TORC.US volatility(beta: 2.43)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while resTORbio's is 2.433. This would suggest that resTORbio's shares are significantly more volatile than the average for this exchange and represent a higher risk.

resTORbio overview

resTORbio, Inc., a clinical-stage biopharmaceutical company, develops medicine to treat aging-related diseases. Its lead program is selectively inhibits the target of rapamycin complex 1 (TORC1), an evolutionary conserved pathway that contributes to the age-related decline in function of various organ systems, including immune, neurologic, and cardiac functions. The company's lead drug candidate is RTB101, an oral, selective, and potent inhibitor of TORC1 that is in Phase 1b/2a clinical trial for the treatment of Parkinson's disease, as well as to treat neurodegenerative diseases. resTORbio, Inc. has collaboration with TrialSpark to investigate RTB-101 for COVID-19 on the Project Covalence platform. resTORbio, Inc. was founded in 2016 and is headquartered in Boston, Massachusetts.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site